Zoekresultaten - 187 results
Reply to 'Low-dose hydroxychloroquine therapy and lower mortality in hospitalized patients with COVID-19: association does not mean causality'.
Publication Type: Peer reviewed scientific article Authors: N Dauby; Lucy Catteau; Joris Hautekiet; Marion Montourcy; E Bottieau; Goetghebeur, E; Dominique Van Beckhoven Source: Int J Antimicrob Agents (2020) Health Topics: COVID-19 Service: Épidémiolog ...
A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the DAWn-Plasma trial.
Therapy COVID-19 Female Global Burden of Disease Hospitalization Humans Immunization, Passive Male mortality Respiration, Artificial SAFETY SARS-CoV-2 Standard of Care Treatment Outcome Abstract: ...
Structural study of l-ascorbic acid 2-phosphate magnesium, a raw material in cell and tissue therapy
Publication Type: Peer reviewed scientific article Authors: X Xu; M Wozniczka; Van Hecke, K; D Buyst; D Mara; C Vervaet; K Herman; Wynendaele, Evelien; Eric Deconinck; De Spiegeleer, Bart Source: Journal of biological Inorganic Chemistry, Volume 25, Issue ...
The lack of K13-propeller mutations associated with artemisinin resistance in Plasmodium falciparum in Democratic Republic of Congo (DRC).
Republic of the Congo Drug Resistance Female Humans Malaria, Falciparum Male middle aged Mutation Plasmodium falciparum Polymorphism, Genetic Young adult Abstract: Artemisinin-based combination therapies ...
Low-dose hydroxychloroquine therapy and mortality in hospitalised patients with COVID-19: a nationwide observational study of 8075 participants
investigated as therapy for COVID-19 across various settings at a total dose usually ranging from 2400 mg to 9600 mg. In Belgium, off-label use of low-dose HCQ (total 2400 mg over 5 days) was recommended for ...
Incidence rate, predictors and outcomes of interruption of HIV care: nationwide results from the Belgian HIV cohort
and were therefore considered as having experienced a real gap in HIV care; they represented 2.3/100 person-years of follow-up. Factors individually associated with HCI were no antiretroviral therapy ...
Collaborative data collection by TREAT-NMD Registries to support post-marketing surveillance in Spinal Muscular Atrophy
around 1:10,000 live births. TREAT- NMD is a neuromuscular network that aims to ensure that the most promising new therapies reach patients as quickly as possible. The TREAT- NMD Global Network of SMA ...
Imported malaria and artemisinin-based combination therapy failure in travellers returning to Belgium: A retrospective study.
residents. Here, we describe recent trends of imported malaria to Belgium and characterize the first cases of P.falciparum failure to artemisinin-based combination therapy (ACT). METHODS: National surveillance ...
Association between diseases and non-conventional therapy use, Belgian Health Interview Survey
Publication Type: Scientific poster, presentation or proceeding Authors: Sabine Drieskens; Stefaan Demarest; Johan Van der Heyden; Jean Tafforeau Source: European Public Health Conference, Lubjana (2018) Health Topics: Health and disease monitoring Surve ...
Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing
identified across nine genes, and individual phenotypes were predicted unless mutations of unknown association were also present. To identify how whole-genome sequencing might direct first-line drug therapy ...